Expression of p16INK4 and retinoblastoma protein Rb in vulvar lesions of Chinese women

被引:28
作者
Chan, MKM [1 ]
Cheung, TH
Chung, TKH
Bao, SY
Zhao, CL
Nobori, T
Wong, YF
机构
[1] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Anat & Cellular Pathol, Shatin, Hong Kong
[2] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Obstet & Gynecol, Shatin, Hong Kong
[3] Zhejinag Med Univ, Gynecol & Obstet Hosp, Hangzhou, Peoples R China
[4] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA
关键词
D O I
10.1006/gyno.1997.4914
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The protein products of the two tumor suppressor genes located on 9p and 13p, p16(INK4) and Rb, respectively, play an important role in regulation of the cell cycle and are implicated in tumorigenesis. We examined 49 cases of benign vulvar lesions, vulvar intraepithelial neoplasia (VIN), and squamous cell carcinoma with immunohistochemical staining to determine expression of p16(INK4) and Rb. All and 86% of benign lesions expressed Rb and p16(INK4) respectively; 40% each of VIN I and VIN III expressed p16(INK4) and Rb, respectively; and 37 and 68% of squamous cell carcinomas expressed p16(INK4) and Rb, respectively. The combination of the lack of p16(INK4) and/or Rb expression increased from benign lesions (14.3%), through VIN I (60%) and VIN III (60%), to invasive squamous cell carcinoma (72%), thus supporting the postulation that alterations in p16(INK4) Or Rb could be significant events in progression of disease. The loss of Rb expression also increased from stage I carcinoma (16.7%) through stage II (26.7%) and III (44.4%), to IV (50%), suggesting that Rb may play an important role in tumor progression. A larger study on VIN lesions and genetic coding is suggested to further investigate the role of p16(INK4) Rb, and other factors in tumorigenesis and progression of vulvar cancers. (C) 1998 Academic Press.
引用
收藏
页码:156 / 161
页数:6
相关论文
共 30 条
[1]   A HUMAN DNA SEGMENT WITH PROPERTIES OF THE GENE THAT PREDISPOSES TO RETINOBLASTOMA AND OSTEOSARCOMA [J].
FRIEND, SH ;
BERNARDS, R ;
ROGELJ, S ;
WEINBERG, RA ;
RAPAPORT, JM ;
ALBERT, DM ;
DRYJA, TP .
NATURE, 1986, 323 (6089) :643-646
[2]   ABERRANT RB GENE-EXPRESSION IN ROUTINELY PROCESSED, ARCHIVAL TUMOR-TISSUES DETERMINED BY 3 DIFFERENT ANTI-RB ANTIBODIES [J].
GERADTS, J ;
HU, SX ;
LINCOLN, CE ;
BENEDICT, WF ;
XU, HJ .
INTERNATIONAL JOURNAL OF CANCER, 1994, 58 (02) :161-167
[3]  
GERADTS J, 1995, CANCER RES, V55, P6006
[4]  
GRUIS NA, 1995, AM J PATHOL, V146, P1199
[5]   ABNORMALITIES IN STRUCTURE AND EXPRESSION OF THE HUMAN RETINOBLASTOMA GENE IN SCLC [J].
HARBOUR, JW ;
LAI, SL ;
WHANGPENG, J ;
GAZDAR, AF ;
MINNA, JD ;
KAYE, FJ .
SCIENCE, 1988, 241 (4863) :353-357
[6]  
HE J, 1995, CANCER RES, V55, P4833
[7]   THE INTERACTION OF RB WITH E2F COINCIDES WITH AN INHIBITION OF THE TRANSCRIPTIONAL ACTIVITY OF E2F [J].
HIEBERT, SW ;
CHELLAPPAN, SP ;
HOROWITZ, JM ;
NEVINS, JR .
GENES & DEVELOPMENT, 1992, 6 (02) :177-185
[8]   POINT MUTATIONAL INACTIVATION OF THE RETINOBLASTOMA ANTIONCOGENE [J].
HOROWITZ, JM ;
YANDELL, DW ;
PARK, SH ;
CANNING, S ;
WHYTE, P ;
BUCHKOVICH, K ;
HARLOW, E ;
WEINBERG, RA ;
DRYJA, TP .
SCIENCE, 1989, 243 (4893) :937-940
[9]  
IGAKI H, 1995, CANCER RES, V55, P3421
[10]   A CELL-CYCLE REGULATOR POTENTIALLY INVOLVED IN GENESIS OF MANY TUMOR TYPES [J].
KAMB, A ;
GRUIS, NA ;
WEAVERFELDHAUS, J ;
LIU, QY ;
HARSHMAN, K ;
TAVTIGIAN, SV ;
STOCKERT, E ;
DAY, RS ;
JOHNSON, BE ;
SKOLNICK, MH .
SCIENCE, 1994, 264 (5157) :436-440